Coronavirus vaccine developer CureVac shares surge in U.S. debut
(Reuters) – Shares of German biotechnology firm CureVac BV nearly tripled in their Nasdaq debut on Friday, marking the first stock market debut [...]
Home »
Biotech company CureVac aims to raise up to $245 million in U.S. IPO
FRANKFURT (Reuters) – CureVac, one of Germany’s leading contenders to develop a COVID-19 vaccine, said it aims to raise up to $245 million [...]
CureVac aims to raise up to $245 million in U.S. IPO
FRANKFURT (Reuters) – CureVac, one of Germany’s leading contenders to develop a COVID-19 vaccine, said it aims to raise up to $245 million [...]
Curevac vaccine: a rush of volunteers for Corona vaccine trial in Tübingen
Around 4,000 Volunteers have reported in the tübingen University hospital as subjects for a Corona vaccine trial. “We are in a luxury situation, [...]